OSE Immunotherapeutics SA(ORPOF)
$4.430.00 (0.00%)
ORPOF
OSE Immunotherapeutics SA earnings date
$4.43
At close:0.00 (0.00%)
OSE Immunotherapeutics SA (ORPOF) Q4 2018 Earnings Report
0 Followers
ORPOF Q4 2018 EPS Results
- Actual EPS
- -$0.26
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.33
ORPOF Q4 2018 Revenue Results
- Actual Revenue
- $4.32M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2018
- Date
- 03/28/2019
- Time
- During Market Hours
- Conference Call
- Thursday, March 28, 2019
ORPOF Upcoming Earnings
OSE Immunotherapeutics SA's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q4 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
ORPOF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | ―- | -1.13 | ― | ― |
| Sep 28, 2026 | 2026 (Q2) | ―- | -0.77 | ― | |
| Apr 30, 2026 | 2025 (Q4) | ―-1.13 | -1.01 | -11.76% (-0.12) | |
| Oct 15, 2025 | 2025 (Q2) | ―-0.77 | 2.95 | -125.99% (-3.72) | |
| Mar 26, 2025 | 2024 (Q4) | ―-1.01 | -0.61 | -67.16% (-0.41) | |
| Sep 26, 2024 | 2024 (Q2) | ―2.95 | -0.72 | 510.63% (+3.67) | |
| Mar 27, 2024 | 2023 (Q4) | ―-0.61 | -0.96 | 36.96% (+0.35) | |
| Sep 27, 2023 | 2023 (Q2) | ―-0.72 | -0.12 | -481.82% (-0.60) | |
| Apr 27, 2023 | 2022 (Q4) | ―-0.96 | -0.33 | -194.83% (-0.63) | |
| Sep 22, 2022 | 2022 (Q2) | ―-0.12 | -0.72 | 82.81% (+0.60) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
